Supports glucose metabolism, insulin sensitivity, and post-meal blood sugar balance with clinically researched botanicals and nutrients.*
What It Does
Glucose Tolerance II with Berberine promotes healthy glucose metabolism, insulin signaling, and balanced postprandial blood sugar levels.* This formula is designed for metabolic health, leveraging targeted botanicals and micronutrients to support liver, muscle, and systemic glucose regulation.*
How It Works
Glucevia™ (European Ash Extract): Clinically studied to enhance post-meal glucose response and support hepatic and muscular glucose uptake.*[1,2]
Berberine: Promotes healthy blood glucose levels and activates AMPK, a key enzyme involved in glucose and lipid metabolism.*[3,4,5]
Chromium Polynicotinate: A niacin-bound trace mineral that supports insulin sensitivity, receptor activity, and carbohydrate metabolism.*[6,7]
Milk Thistle (Silymarin): Traditionally used for liver support; silymarin also supports insulin function and lipid metabolism, and may act well alongside berberine.*[8,9]
Resveratrol: A polyphenol with antioxidant properties shown to support insulin sensitivity and metabolic markers.*[10,11,12]
Biotin: A B vitamin that aids carbohydrate metabolism and, in combination with chromium, supports glucose regulation.*[6]
Who It’s For
For individuals seeking nutritional support for blood sugar balance, post-meal glycemic response, or maintenance of insulin function as part of a comprehensive metabolic health strategy.*
Special Features
Includes Glucevia™, a clinically studied extract, and synergistic nutrients like berberine, silymarin, chromium, resveratrol, and biotin each included at levels consistent with clinical research.*
Glucose Tolerance II with Berberine provides comprehensive, evidence-based support for healthy blood sugar metabolism and metabolic resilience.*
References
1. Visen P, et al. J Ethnopharmacol. 2009;126(2):226–32.
2. Zulet MA, et al. Phytomedicine. 2014;21(10):1162–9.
3. Neag MA, et al. Front Pharmacol. 2018;9. doi:10.3389/fphar.2018.00557
4. Yin J, et al. Am J Physiol Endocrinol Metab. 2007;294(1):E148–56.
5. Xie W, et al. Front Pharmacol. 2022;13. doi:10.3389/fphar.2022.1015045
6. Albarracin CA, et al. Diabetes Metab Res Rev. 2007;24(1):41–51.
7. Suksomboon N, et al. J Clin Pharm Ther. 2014;39(3):292–306.
8. MacDonald-Ramos K, et al. Int J Mol Sci. 2024;25(4):2050. doi:10.3390/ijms25042050
9. Fogacci F, et al. Phytother Res. 2019;33(4):862–70.
10. Wong RHX, Howe PRC. Nutrients. 2018;10(9):1160. doi:10.3390/nu10091160
11. Liu K, et al. Am J Clin Nutr. 2014;99(6):1510–9.
12. Bhatt JK, et al. Nutr Res. 2012;32(7):537–41.
